191 related articles for article (PubMed ID: 35473418)
1. Mediators of cognitive impairment in cerebral amyloid angiopathy.
Durrani R; Wang M; Cox E; Irving E; Saad F; McCreary CR; Beaudin AE; Gee M; Nelles K; Sajobi TT; Ismail Z; Camicioli R; Smith EE
Int J Stroke; 2023 Jan; 18(1):78-84. PubMed ID: 35473418
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy.
McCreary CR; Beaudin AE; Subotic A; Zwiers AM; Alvarez A; Charlton A; Goodyear BG; Frayne R; Smith EE
Neuroimage Clin; 2020; 27():102280. PubMed ID: 32521475
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
[TBL] [Abstract][Full Text] [Related]
4. Peak width of skeletonized mean diffusivity in cerebral amyloid angiopathy: Spatial signature, cognitive, and neuroimaging associations.
Zanon Zotin MC; Schoemaker D; Raposo N; Perosa V; Bretzner M; Sveikata L; Li Q; van Veluw SJ; Horn MJ; Etherton MR; Charidimou A; Gurol ME; Greenberg SM; Duering M; Dos Santos AC; Pontes-Neto OM; Viswanathan A
Front Neurosci; 2022; 16():1051038. PubMed ID: 36440281
[TBL] [Abstract][Full Text] [Related]
5. Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.
Subotic A; McCreary CR; Saad F; Nguyen A; Alvarez-Veronesi A; Zwiers AM; Charlton A; Beaudin AE; Ismail Z; Pike GB; Smith EE
J Alzheimers Dis; 2021; 81(4):1663-1671. PubMed ID: 33998545
[TBL] [Abstract][Full Text] [Related]
6. Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.
Xiong L; Davidsdottir S; Reijmer YD; Shoamanesh A; Roongpiboonsopit D; Thanprasertsuk S; Martinez-Ramirez S; Charidimou A; Ayres AM; Fotiadis P; Gurol E; Blacker DL; Greenberg SM; Viswanathan A
J Alzheimers Dis; 2016 Mar; 52(1):171-8. PubMed ID: 27060947
[TBL] [Abstract][Full Text] [Related]
7. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy.
Raposo N; Zanon Zotin MC; Schoemaker D; Xiong L; Fotiadis P; Charidimou A; Pasi M; Boulouis G; Schwab K; Schirmer MD; Etherton MR; Gurol ME; Greenberg SM; Duering M; Viswanathan A
AJNR Am J Neuroradiol; 2021 May; 42(5):875-881. PubMed ID: 33664113
[TBL] [Abstract][Full Text] [Related]
8. Association Between Hippocampal Volumes and Cognition in Cerebral Amyloid Angiopathy.
Perosa V; Zanon Zotin MC; Schoemaker D; Sveikata L; Etherton MR; Charidimou A; Greenberg SM; Viswanathan A
Neurology; 2024 Jan; 102(2):e207854. PubMed ID: 38165326
[TBL] [Abstract][Full Text] [Related]
9. Peak width of skeletonized mean diffusivity and cognitive performance in cerebral amyloid angiopathy.
Horn MJ; Gokcal E; Becker JA; Das AS; Schwab K; Zanon Zotin MC; Goldstein JN; Rosand J; Viswanathan A; Polimeni JR; Duering M; Greenberg SM; Gurol ME
Front Neurosci; 2023; 17():1141007. PubMed ID: 37077322
[TBL] [Abstract][Full Text] [Related]
10. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.
Fotiadis P; van Rooden S; van der Grond J; Schultz A; Martinez-Ramirez S; Auriel E; Reijmer Y; van Opstal AM; Ayres A; Schwab KM; ; Hedden T; Rosand J; Viswanathan A; Wermer M; Terwindt G; Sperling RA; Polimeni JR; Johnson KA; van Buchem MA; Greenberg SM; Gurol ME
Lancet Neurol; 2016 Jul; 15(8):811-819. PubMed ID: 27180034
[TBL] [Abstract][Full Text] [Related]
11. Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy.
Jo S; Cheong EN; Kim N; Oh JS; Shim WH; Kim HJ; Lee SJ; Lee Y; Oh M; Kim JS; Kim BJ; Roh JH; Kim SJ; Lee JH
J Alzheimers Dis; 2022; 86(2):667-678. PubMed ID: 35124637
[TBL] [Abstract][Full Text] [Related]
12. Association of Long-Term Blood Pressure Variability with Cerebral Amyloid Angiopathy-related Brain Injury and Cognitive Decline.
Sveikata L; Zotin MCZ; Schoemaker D; Ma Y; Perosa V; Chokesuwattanaskul A; Charidimou A; Duering M; Gurol EM; Assal F; Greenberg SM; Viswanathan A
medRxiv; 2024 Feb; ():. PubMed ID: 38464316
[TBL] [Abstract][Full Text] [Related]
13. Microstructural white matter integrity in relation to vascular reactivity in Dutch-type hereditary cerebral amyloid angiopathy.
Schipper MR; Vlegels N; van Harten TW; Rasing I; Koemans EA; Voigt S; Luca A; Kaushik K; van Etten ES; van Zwet EW; Terwindt GM; Biessels GJ; van Osch MJ; van Walderveen MA; Wermer MJ
J Cereb Blood Flow Metab; 2023 Dec; 43(12):2144-2155. PubMed ID: 37708241
[TBL] [Abstract][Full Text] [Related]
14. Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy.
Banerjee G; Wilson D; Ambler G; Osei-Bonsu Appiah K; Shakeshaft C; Lunawat S; Cohen H; Yousry T; Lip GYH; Muir KW; Brown MM; Al-Shahi Salman R; Jäger HR; Werring DJ;
Stroke; 2018 Jan; 49(1):40-45. PubMed ID: 29247143
[TBL] [Abstract][Full Text] [Related]
15. Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy.
Xu J; Su Y; Fu J; Wang X; Nguchu BA; Qiu B; Dong Q; Cheng X
Eur J Neurol; 2022 Oct; 29(10):2895-2904. PubMed ID: 35712978
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
[TBL] [Abstract][Full Text] [Related]
17. Cerebral Cortical Microinfarcts on Magnetic Resonance Imaging and Their Association With Cognition in Cerebral Amyloid Angiopathy.
Xiong L; van Veluw SJ; Bounemia N; Charidimou A; Pasi M; Boulouis G; Reijmer YD; Giese AK; Davidsdottir S; Fotiadis P; Valenti R; Riley G; Schwab K; Gurol EM; Biffi A; Greenberg SM; Viswanathan A
Stroke; 2018 Oct; 49(10):2330-2336. PubMed ID: 30355109
[TBL] [Abstract][Full Text] [Related]
18. Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid Angiopathy.
Beaudin AE; McCreary CR; Mazerolle EL; Gee M; Sharma B; Subotic A; Zwiers AM; Cox E; Nelles K; Charlton A; Frayne R; Ismail Z; Beaulieu C; Jickling GC; Camicioli RM; Pike GB; Smith EE
Neurology; 2022 Apr; 98(17):e1716-e1728. PubMed ID: 35210294
[TBL] [Abstract][Full Text] [Related]
19. Domain-specific neuropsychological investigation of CAA with and without intracerebral haemorrhage.
Chan E; Bonifacio GB; Harrison C; Banerjee G; Best JG; Sacks B; Harding N; Del Rocio Hidalgo Mas M; Jäger HR; Cipolotti L; Werring DJ
J Neurol; 2023 Dec; 270(12):6124-6132. PubMed ID: 37672105
[TBL] [Abstract][Full Text] [Related]
20. Temporal Ordering of Biomarkers in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
Koemans EA; Rasing I; Voigt S; van Harten TW; van der Zwet RGJ; Kaushik K; Schipper MR; van der Weerd N; van Zwet EW; van Etten ES; van Osch MJP; Kuiperij B; Verbeek MM; Terwindt GM; Greenberg SM; van Walderveen MAA; Wermer MJH
Stroke; 2024 Apr; 55(4):954-962. PubMed ID: 38445479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
